BRASILIA (Reuters) - Brazilian lab and hospital group DASA S.A. said on Wednesday it has agreed to conduct clinical Phase 2 and 3 trials in Brazil for a COVID-19 vaccine developed by COVAXX, a unit of ...
BRASILIA (Reuters) - Brazilian lab and hospital group DASA SA said on Thursday it has signed an agreement to acquire the Grupo Leforte hospital and clinic company for 1.77 billion reais ($343.6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results